Cursos

Actividades Académicas

Atrás

XIX INTERNATIONAL SCHOOL OF PHARMACOLOGY ‹TEÓFILO HERNANDO›. ADVANCED THERAPIES FOR HUMAN DISEASE

Información General

Información

_Información solicitud_Información solicitud

PROGRAMA DEL CURSO

Código
654E
Horas

Fecha
20 Jun 2022
24 Jun 2022
Precio
140 € Tarifa C
Tipo
Escuela
Temática
Biología y Biomedicina
ECTS
1

Sede donde se gestiona

Santander

Lugar de impartición

Santander - Península de la Magdalena (Rector Ernest Lluch)

Dirección

Michael Duchen
University College London, UK

Antonio G. García
Universidad Autónoma de Madrid, Spain


Secretaría

Luis Gandía Juan
Universidad Autónoma de Madrid, Spain

ORGANIZADO EN COLABORACIÓN CON


ORGANIZADO EN COLABORACIÓN CON

Descripción de la actividad

Central stage in the fascinating field of drug discovery and development is the identification of drugable targets implicated in the pathogenesis of a given human disease. Hence, in this School frontier knowledge in such endeavour will be analysed by worldwide renowned scientists in the field of neuroscience, mitochondria, the epilepsies, Alzheimer´s disease, cell therapies and other advanced therapies. This XIX edition of the International Teófilo Hernando’s Pharmacology School will enlighten young PhD and postdoctoral students, as well as graduate students in the area of biomedical sciences. Additionally, PhD and postdoctoral students will have the opportunity of presenting their work to the class and professors. It is a tradition in this School that professors and students read a poem to the class dealing with their own culture. In doing so, humanities and science walk hand in hand, as in renaissance times, 500 years ago. Hence, the School is a science and humanistic unique experience that reminds the foundation of UIMP by poets and scientists near 100 years ago.

 

The International Pharmacology School “Teófilo Hernando” was initiated in 1996, in the frame of the summer courses of UIMP. At that time, Rector José Luis García Delgado invited professor Antonio G. García (Universidad Autónoma de Madrid) to organise this School.

 

The School was named after Teófilo Hernando, a Spanish MD/PhD pharmacologist who was trained under Oswald Schmiedeberg at Strassbourg, the first formal Pharmacology School where many pharmacologists throughout the word were trained at the end of the XIX century and the beginning of the XX century and then developed the subject of basic and clinical pharmacology in their own countries. Teófilo Hernando introduced pharmacology as an independent teaching and science subject at the Universidad Complutense de Madrid, along the first three decades of the XX century this academic matter soon spread out to several Spanish universities by pharmacologists trained under professor Hernando. He trained numerous other disciples that extended the subject to many other Spanish universities along the XX century.

 

The format of a UIMP’s School (“Escuela”) is based in the critical analysis in the frontier of knowledge of a given scientific topic, along a week (Monday to Friday) by scientists and students of all over the world. Two sessions are delivered in the morning by invited scientists, lasting each one two hours, with vivid discussions. In the afternoon, PhD students and postdocs present their ongoing scientific work as short oral communications. Emphasis is always made in the identification of new biological drug targets that illuminate the design, synthesis and development of new medicines to treat human diseases.

Participantes

DIRECCIÓN

Michael Duchen
University College London, UK

Antonio G. García
Universidad Autónoma de Madrid, Spain

SECRETARÍA

Luis Gandía Juan
Universidad Autónoma de Madrid, Spain

PARTICIPANTES

Natividad Alcorta Sevillano
Instituto Investigación Sanitaria Biocruces Bizkaia

Katherine Benson
Royal College of Surgeons in Ireland, Ireland

María A. Blasco
Centro Nacional de Investigaciones Oncológicas, Madrid, Spain

Elena Caldero Escudero
Universidad de Valladolid

Anitta Rose Chacko
University College London

Tobias Engel
Royal College of Surgeons in Ireland, Dublin, Ireland

Olivia Gillham
University College London

Anna Lisa Giuliani
University of Ferrara, Ferrara, Italy

Miguel Ángel Huerta Martínez
Universidad de Granada

Enrique Jiménez Madrona
Universidad de Sevilla

Michael Kossifos
University College London

Swati Kumar
University College London

Ashley Lam
University College London

José Alberto López Domínguez
Institute for Research in Biomedicine, Barcelona, Spain

Andrea López Martínez
Instituto Investigación Sanitaria Biocruces Bizkaia

Victoria Maneu Flores
Universidad de Alicante

Cristina Molina López
Instituto Murciano de Investigación Biosanitaria

Carlos Núñez de la Calle
Universidad Complutense de Madrid

Adrián Núñez Sancho
Universidad Complutense de Madrid

Marina Paredes Nieto
Instituto Teófino Hernando/UAM

Aitor Picos Martínez
Universidad de Santiago de Compostela

Silvia Romero Sanz
Universidad de Valladolid

Miriam Santos Caballero
Universidad de Granada

Francesco Saverio Tedesco
University College London, UK

Myriam Torres Rico
Instituto Teófilo Hernando/UAM

Gabriel Valdebenito Valdebenito
University College London

Natalie Yivgi-Ohana
MINOVIA, Israel

Rafael Yuste
Columbia University, New York, USA

Programa

Lunes, 20 Junio 2022

10:00
School inauguration by directors and UIMP academic authority
10:30
Senolytic therapies in cancer and other diseases
José Alberto López Domínguez
12:00
Telomers and telomerase in cancer and ageing
María A. Blasco
15:00
Young Researcher Presentations (YRP-1)
Coordinator
Luis Gandía Juan
Developing therapies for retinal protection
Victoria Maneu Flores
Laparotomy in the mouse: a traslacional model of postoperative pain
Miriam Santos Caballero
Multimodal analgesia: sigma-1 receptor blockade to increase the therapeutic potential of NSAIDs
Miguel Ángel Huerta Martínez
Effect of kinurenin monoxygenase inhibition by Ro 61-8048 on the developtment of addictive behaviors induced by fentanyl
Carlos Núñez de la Calle
Antiproliferative effect of boldine on Neural Progenitor Cells of the rodent Subventricular Zone and glioblastoma multiforme cells
Enrique Jiménez Madrona

Martes, 21 Junio 2022

10:00
Mitochondrial pathways as therapeutic targets for human disease
Michael Duchen
12:00
Mitochondrial cell therapy
Natalie Yivgi-Ohana
15:00
Young Researcher Presentations (YRP-2)
Coordinator
Luis Gandía Juan
Drug screeningon OI human experimental models: increasing the osteoanabolic potential of MSCs
Natividad Alcorta Sevillano
Characterization of myotonic dystrophy type I cell models for drug screening
Andrea López Martínez
Submaximal inhibution of sca-1 (SERCA) enhances lifespan and healthspan in a chemical model of Parkinson's disease in C. elegans
Silvia Romero Sanz
Modulation of calcium homeostasis improves genertic and sporadic Alzheimer's disease in Caenorhabditis elegans models
Elena Caldero Escudero
Evaluation of sodium nitroprusside effects on bEnd.3 cells after oxygen and glucose deprivation and reoxygenation; a disappointing story
Aitor Picos Martínez

Miércoles, 22 Junio 2022

10:00
Reprogramming human skeletal muscle regeneration: new strategies for neuromuscular modelling and therapy
Francesco Saverio Tedesco
12:00
Neurodegeneration, neuroprotection and drug repositioning
Antonio G. García
15:00
Young Researcher Presentations (YRP-3)
Coordinator
Luis Gandía Juan
Structural and interactions studies of chondroitin sulfate mimetics with growth factors
Myriam Torres Rico
In silico Drug Repositioning for Neurodegenerative Diseases
Marina Paredes Nieto
Using iPSC-derived neural cells to model Down syndrome-associated neurodegeneration and identify new therapeutic targets
Olivia Gillham
Exploring novel treatment strategies for primary mitochondrial disease
Anitta Rose Chacko
Exploring novel treatment strategies to rescue mitochondrial function in cell models of the m.3243A G mutation using hiPSC-derived myotubes
Gabriel Valdebenito Valdebenito

Jueves, 23 Junio 2022

10:00
Targeting mRNA polyadenylation as a novel therapeutic approach to treat drug refractory epilepsy
Tobias Engel
12:00
Epilepsy as a model for precision therapeutics
Katherine Benson
15:00
Young Researcher Presentations (YRP-4)
Coordinator
Luis Gandía Juan
Effect of nanoplastics on inflammasome activation
Adrián Núñez Sancho
NLRP3 with mutations related to Cryopyrin associated-periodic syndromes results in a constitutively active inflammasome
Cristina Molina López
Using restriction endonucleases for targeting mtDNA for cancer gene therapy
Swati Kumar
Bioenergetic characterisation of c-Myc driven tumours
Michael Kossifos
Bioenergetic characterisation of c-Myc driven tumours
Ashley Lam

Viernes, 24 Junio 2022

10:00
Targeting purinergic check-points in inflammation and cancer
Anna Lisa Giuliani
12:00
Closing lecture
The novel neurotechnologies: implication for science and medicine
Rafael Yuste
13:00
Closing ceremony
Michael Duchen
Antonio G. García